Gene Query: INPPL1

Dataset Description Geneva Score
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 39.31
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 36.66
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 32.38
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 32.34
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 32.28
Altering cancer transcriptomes using epigenomic inhibitors 32.28
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 26.88
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 26.68
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 25.68
DART-seq: an antibody-free method for global m6A detection 25.58
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 24.99
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 24.84
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 22.94
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 22.74
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 22.51
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 21.55
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 21.03
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 20.61
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 20.61
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 20.27
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 19.9
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 19.89
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 19.67
CHCHD2 gene KO effect in iPSC drived motor neurons 19.34
DIGIT regulates endoderm differentiation of human embryonic stem cells 18.96
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 18.78
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 18.54
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 18.34
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 18.32
Splicing and epigenetic factors jointly regulate epidermal differentiation 18.1
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 18.07
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 17.97
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 17.76
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 17.71
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 17.38
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 17.37
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 17.29
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 17.21
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 17.21
Gene Expression Profiling of SPOP Knocked Down Cell 17.18
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 17.08
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 16.95
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 16.76
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 16.65
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 16.63
Expression profiling of MCF-7 cells with treatment of TCDD 16.63
CHCHD10 gene KO effect in iPSC drived motor neurons 16.63
CD86 regulates a pro-survival signal in myeloma cells 16.52
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 16.31
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 16.29
Mitochondrial dsRNA triggers antiviral signalling in humans 16.13
TFAP2C signalling in human fibroblasts 16.08
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 15.73
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 15.4
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 15.33
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 15.33
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 15.26
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 15.06
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 15.01
Total RNA-seq in ALL-SIL upon JQ1 inhibition 14.98
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 14.94
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 14.94
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 14.87
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 14.77
MCF10A H-Ras RNA-Seq 14.61
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 14.6
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 14.6
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 14.48
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 14.48
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 14.46
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 14.42
mRNA expression in human DAOY cells 14.23
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 14.23
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 14.12
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 14.12
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 14.1
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 14.1
Depicting early human development and germ cell origin with porcine embryos 14.08
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 14.01
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 14.01
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 13.98
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 13.98
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 13.89
KLF6-dependent transcription in renal cancer cells 13.83
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 13.76
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 13.75
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 13.75
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 13.75
Intrahepatic MAIT cell gene expression revealed by RNA-seq 13.69
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 13.59
RNA-sequencing of human liver tissue 13.49
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 13.45
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 13.39
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 13.3
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 13.3
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 13.18
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 13.17
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 13.17
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 13.08
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 12.89
Global transcriptome analysis of HAP1 cells 12.81
Searching for target genes of miR-508/509/506/514 in HCT116 cells 12.79
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 12.74
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 12.68
Studying the selectivity of a small molecule Synucleozid on transcriptome 12.65
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 12.65
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 12.6
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 12.57
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 12.45
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 12.32
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 12.29
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 12.13
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 12.07
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 12.03
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 12.03
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 11.83
Identification of Atrial Fibrillation associated genes and functional non-coding variants 11.81
Gene expression profiling of human and murine in vitro muscle differentiation 11.81
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 11.81
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 11.71
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 11.62
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 11.62
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 11.6
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 11.6
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 11.6
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 11.59
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 11.58
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 11.57
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 11.49
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 11.49
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 11.46
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 11.45
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 11.31
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 11.27
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 11.22
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 11.2
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 11.19
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 11.19
Role of microRNAs in the interaction between Salmonella and the host cell 11.12
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 11.05
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 11.03
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 11.02
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 11.01
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 10.99
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 10.98
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 10.97
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 10.83
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 10.81
Mechanistic Model-Guided Study of Embryonic Morphogenesis 10.79
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 10.73
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 10.66
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 10.65
Comparative Analysis of Cas9 Activators Across Multiple Species 10.63
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 10.6
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 10.57
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 10.56
RNA-sequencing in irradiated and normal A549 cells. 10.49
Rorc disruption in human FG pancreatic cancer cells 10.41
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 10.39
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 10.39
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  10.31
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 10.29
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 10.29
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 10.21
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 10.13
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 10.12
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 10.08
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 10.0
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 9.98
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 9.94
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 9.81
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 9.81
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 9.78
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 9.78
Global response to chemotherapy-induced apoptosis 9.74
Effect of PBK knockdown on C4-2 cell transcriptome 9.72
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 9.65
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 9.65
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 9.64
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 9.64
Modeling Familial Cancer with iPSC Approaches 9.64
Human cells contain natural double-stranded RNAs with potential regulatory capacity 9.59
RNA-sequencing of human tendon after injury 9.56
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 9.52
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 9.51
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 9.5
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 9.49
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 9.41
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 9.37
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 9.36
The transcriptome and chromatin accessbility landscape of mammalian germline 9.31
T47D RNA-seq and ChrRNA-seq data 9.28
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 9.28
NAPRT activation of macrophages 9.28
Genome wide expression change by RNF168 knocking down in NEC cells 9.27
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 9.2
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 9.19
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 9.18
Postnatal lipids drive hepatocyte maturation 9.1
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 9.06
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 9.03
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 9.03
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 9.02
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 9.02
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 8.96
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 8.95
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 8.95
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 8.88
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 8.88
Expression level comparison under dividing and quiescent states in human primary fibroblasts 8.87
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 8.84
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 8.8
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 8.8
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 8.79
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 8.76
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 8.73
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 8.71
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 8.71
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 8.71
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 8.7
Landscape and variation of RNA secondary structure across the human transcriptome 8.68
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 8.65
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 8.61
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 8.61
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 8.6
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 8.6
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 8.59
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 8.59
RNA-Seq analysis of breast cancer cells after shikonin treatment 8.48
Transcriptomes of human monocytes after ex vivo exposure to uric acid 8.45
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 8.44
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 8.43
HNF1A deficiency impairs β-cell fate, granule maturation and function 8.43
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 8.42
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 8.41
Real-time observation of light-controlled transcription in living cells 8.41
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 8.37
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 8.36
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 8.34
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 8.3
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 8.27
RNA-seq of YB5 cells treated with Proscillaridin A 8.25
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 8.22
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 8.19
ZIKV infection of monocytes activates inflammasome pathways 8.16
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 8.16
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 8.13
RNA transcriptome analysis during HSV-1 infection 8.11
High-throughput sequencing of pluripotent cells 8.09
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 8.0
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 8.0
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 7.99
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 7.99
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 7.96
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 7.94
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 7.84
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 7.81
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 7.81
Activity-dependent transcriptional changes in human neurons 7.78
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 7.72
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 7.65
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 7.61
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 7.59
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 7.53
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 7.51
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 7.5
Loss of CREBBP results in gene expression repression in lymphoma cells 7.37
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 7.37
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 7.36
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 7.19
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 7.18
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 7.17
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 7.17
TT-Seq captures the human transient transcriptome 7.15
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 7.12
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 7.09
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 7.09
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 7.03
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 7.03
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 7.03
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 6.98
hnRNP C is a key regulator of protein synthesis in mitosis 6.97
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 6.94
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 6.94
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 6.92
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 6.92
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 6.92
Exploring the RNA landscape of endothelial exosomes 6.88
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 6.87
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 6.71
RNA polymerase in pre-B-ALL cell lines 6.69
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 6.63
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 6.63
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 6.62
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 6.62
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 6.62
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 6.53
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 6.44
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 6.44
Human embryonic stem cells in E8 and AKIT culture medium 6.43
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 6.43
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 6.42
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 6.36
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 6.36
METTL3 and WTAP 6.36
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 6.32
Genome wide miR-191 target profile determined by RIP and gene expression profiling 6.3
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 6.3
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 6.23
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 6.22
Effect of CHKA knockdown on C4-2 cell transcriptome 6.19
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 6.18
RNAseq of T-ALL upon long non coding rna purturbation 6.13
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 6.04
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 6.01
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 5.97
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 5.97
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 5.91
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 5.91
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 5.89
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 5.85
RNAseq Study in CC-671 Treated Cal-51 Cells 5.81
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 5.76
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 5.7
Toxoplasma gondii infection of human retinal pigment epithelial cells 5.67
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 5.62
Primary Human B-cell Temporal Response to CD40L Stimulation 5.62
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 5.53
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 5.49
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 5.45
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 5.42
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 5.42
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 5.42
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 5.34
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 5.3
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 5.25
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 5.18
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 5.14
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 5.14
RNA sequencing of mechanically strained NHEKs and control NHEKs 4.95
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 4.74
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 4.74
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 4.72
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 4.72
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 4.67
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 4.61
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 4.59
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 4.59
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 4.48
Effect of BB608 on Gene Expression in HNSCC Cell Line 4.45
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 4.42
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 4.3
Trascriptome of thyroid cancer-induced macrophages 4.28
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 4.23
The cohesin release factor WAPL restricts chromatin loop extension. 4.23
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 4.2
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 4.19
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 4.19
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 4.15
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 4.14
MRTF activates TEAD-YAP target gene expression 4.14
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 4.14
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 4.1
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 4.09
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 4.08
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 3.99
ADAR1-editing of cellular and measles virus-derived duplex RNA 3.99
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 3.97
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.97
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.93
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 3.84
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 3.84
RNA-seq of MDA-MB-231 cells with TET1 knockout 3.83
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 3.81
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 3.75
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 3.72
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 3.62
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 3.61
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 3.54
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 3.54
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 3.53
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 3.52
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 3.5
Transcriptome analysis of peripheral blood monocytes 3.5
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.46
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.23
Effect of BMP inhibition or stimulation of primary human keratinocytes 3.09
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 3.09
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 3.07
Gene induction by the USP6 oncogene in response to interferon 3.05
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 3.0
miR-93 Targets in Human Endothelial Cells 2.99
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 2.99
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.98
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.96
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.95
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 2.86
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 2.81
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 2.81
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 2.81
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.81
Recovery and analysis of nascent RNA 2.73
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 2.73
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.73
Gene expression regulated by CSA and CSB in neuroblastoma cell line 2.71
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 2.67
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 2.44
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 2.41
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.37
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.37
Gene expression profile of human placenta from T. Cruzi infected mothers 2.33
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.26
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.26
Widespread regulated alternative splicing of single codons accelerates proteome evolution 2.24
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 2.23
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 2.23
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.22
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 2.19
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 2.17
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 2.16
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 2.09
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 2.09
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 2.06
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 2.03
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 1.96
6mer seed toxicity in viral microRNAs 1.94
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.87
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 1.82
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 1.77
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 1.76
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.75
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.75
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.61
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 1.6
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.52
Oncogenic roles of ARID5B in T-ALL 1.49
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.49
Regulation of highly expressed hCINAP on translatome 1.44
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.43
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.39
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 1.38
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 1.33
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.32
Gene expression profiling in metabolically heterogeneous human lung tumors 1.31
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 1.3
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 1.27
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.25
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.19
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 1.19
RNA expression profiles comparing primary and omental ovarian carcinoma samples 1.19
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.17
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 1.15
K562 polyA RNA-Seq 1.14
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.08
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.08
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 1.05
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.05
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 1.04
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 1.03
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 1.03
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.03
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.99
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.95
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.95
The pioneer factor CEBPA modulates vitamin D signaling 0.95
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.93
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.89
Metabolism as an early predictor of DPSCs aging 0.89
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.86
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.86
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.82
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.82
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 0.81
RNA-seq of CD33 KO and control HSPCs 0.76
Transcriptome landscape of HeLa response upon triamcinolone acetonide 0.72
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.72
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.69
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.58
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.57
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.57
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 0.55
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.53
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.49
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.49
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.49
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.45
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.44
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 0.43
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.25
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.25
Hepatic transcriptome of pediatric hepatoblastoma. 0.22
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.22
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.2
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.2
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 0.19
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.18
MHC Transcriptomic landscape at haplotype-specific resolution 0.09
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.08
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.01
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation